---
title: "GRAVETT DAVID M. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/54ea0fd4-a831-5fbf-8ce4-5a0ecf813dfe
json: https://whiteintel.dev/api/public/dossier/54ea0fd4-a831-5fbf-8ce4-5a0ecf813dfe
identifier: sec:0001631291
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GRAVETT DAVID M.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001631291`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/54ea0fd4-a831-5fbf-8ce4-5a0ecf813dfe  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/54ea0fd4-a831-5fbf-8ce4-5a0ecf813dfe  

## Ownership & control

### Holdings / subsidiaries

- **KalVista Pharmaceuticals, Inc.** (officer) — https://whiteintel.dev/entity/ed4c5bbb-879b-50b0-9ddb-7a7e6a85aaba

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GRAVETT DAVID M.**. Human view: https://whiteintel.dev/entity/54ea0fd4-a831-5fbf-8ce4-5a0ecf813dfe · Structured JSON: https://whiteintel.dev/api/public/dossier/54ea0fd4-a831-5fbf-8ce4-5a0ecf813dfe._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._